FDA approves high-risk neuroblastoma treatment for kids and adults
The FDA approved US WorldMeds’ eflornithine as a therapy to reduce the risk of relapse in adult and pediatric patients with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
